Skip to main content
Log in

Safety Profile of Extended Release Formulation of Nimesulide in Asian Indian Population: A Prescription Event Monitoring Programme

  • Abstract
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rainsford KD. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions. Rheumatology 1999; 38(suppl.1):4–10

    Article  PubMed  CAS  Google Scholar 

  2. Boelsterli UA. Nimesulide and hepatic adverse effects: roles of reactive metabolites and host factors. Int J Clin Pract Suppl 2002; 128:30–6

    PubMed  CAS  Google Scholar 

  3. Conforti A, Leone R, Moretti Ugo, et al. Adverse Drug Reactions Related to the Use of NSAIDs with a Focus on Nimesulide: Results of Spontaneous Reporting from a Northern Italian Area. Drug Safety 2001; 24(14):1081–90

    Article  PubMed  CAS  Google Scholar 

  4. Summary of Product Characteristics: — Nimesulide 100mg Tablet, http://www.emea.eu.int/pdfs/human/referral/nimesulide/308603en.pdf.CPMP/3086/03-REV.1EMEA 2004.

  5. Rabasseda X. Safety profile of Nimesulide: ten years of clinical experience. Drugs of Today Vol.33 Suppl.I, 1997

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, M., Chatterjee, A., Gupta, S.K. et al. Safety Profile of Extended Release Formulation of Nimesulide in Asian Indian Population: A Prescription Event Monitoring Programme. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00029

Keywords

Navigation